Published in Arterioscler Thromb Vasc Biol on August 01, 2012
Targeting Inflammation Using Salsalate for Type 2 Diabetes-stage II (TINSAL-T2D-II) | NCT00799643
Heat Therapy in Patients With Type 2 Diabetes Mellitus (HEATED) | NCT05237219
Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science (2013) 3.64
Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol (2014) 1.76
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. J Diabetes Investig (2013) 1.55
N,N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth. Am J Pathol (2013) 1.43
Leukotriene production is increased in abdominal obesity. PLoS One (2014) 1.40
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism (2013) 1.27
Diabetes and risk of cancer. ISRN Oncol (2013) 1.06
RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice. Diabetes (2014) 1.05
Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension. Antioxid Redox Signal (2013) 1.04
Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice. Proc Natl Acad Sci U S A (2013) 1.04
Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. Biomark Res (2013) 1.03
Overnutrition, mTOR signaling, and cardiovascular diseases. Am J Physiol Regul Integr Comp Physiol (2014) 1.01
Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial. Arthritis Res Ther (2013) 0.99
Role of adipose specific lipid droplet proteins in maintaining whole body energy homeostasis. Biochim Biophys Acta (2013) 0.99
The role of JAK-STAT signaling in adipose tissue function. Biochim Biophys Acta (2013) 0.99
Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes. Arch Pharm Res (2013) 0.99
RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication. Front Endocrinol (Lausanne) (2013) 0.99
Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med (2013) 0.95
Serum immunoglobulin M concentration is positively related to metabolic syndrome in an adult population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study. PLoS One (2014) 0.94
Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One (2014) 0.93
Vegetarian diets and cardiovascular risk factors in black members of the Adventist Health Study-2. Public Health Nutr (2014) 0.91
Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J Biol Chem (2013) 0.91
Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells. Exp Ther Med (2013) 0.91
Human adipose dynamics and metabolic health. Ann N Y Acad Sci (2013) 0.90
Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr (2014) 0.89
Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. Medicine (Baltimore) (2015) 0.89
Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid Med Cell Longev (2013) 0.89
The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies. PLoS One (2013) 0.88
Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice. Am J Physiol Heart Circ Physiol (2015) 0.88
Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm (2013) 0.87
Progranulin: at the interface of neurodegenerative and metabolic diseases. Trends Endocrinol Metab (2013) 0.86
Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions. Nutrients (2015) 0.86
DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes. Cardiorenal Med (2013) 0.86
Obesity and metabolic inflammation. Drug Discov Today Dis Mech (2013) 0.85
Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion. Nat Commun (2016) 0.85
Scientific Validation of Gentiana kurroo Royle for Anti-Inflammatory and Immunomodulatory Potential. ISRN Inflamm (2014) 0.84
Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis (2013) 0.83
Oxidative damage and inflammation in obese diabetic Emirati subjects supplemented with antioxidants and B-vitamins: a randomized placebo-controlled trail. Nutr Metab (Lond) (2013) 0.83
Lifestyle effects on hematopoiesis and atherosclerosis. Circ Res (2015) 0.83
Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway. PLoS One (2014) 0.83
Hepatic function and the cardiometabolic syndrome. Diabetes Metab Syndr Obes (2013) 0.83
Metabolic syndrome, sarcopenia and role of sex and age: cross-sectional analysis of Kashiwa cohort study. PLoS One (2014) 0.82
Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice. PLoS One (2014) 0.82
Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol (2014) 0.81
Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone. PLoS One (2013) 0.81
Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study. Cardiovasc Diabetol (2015) 0.81
Association between prostate cancer and urinary calculi: a population-based study. PLoS One (2013) 0.81
Immune Mechanisms Linking Obesity and Preeclampsia. Biomolecules (2015) 0.81
Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes (2013) 0.80
Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats. Endocrinology (2014) 0.80
The effect of pioglitazone on circulating interleukin-10 and tumor necrosis factor-alpha levels in a patient with metabolic syndrome: A randomized, double-blind controlled trial. ARYA Atheroscler (2015) 0.80
Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study. Sci Rep (2016) 0.80
DUSP1 Gene Polymorphisms Are Associated with Obesity-Related Metabolic Complications among Severely Obese Patients and Impact on Gene Methylation and Expression. Int J Genomics (2013) 0.79
Right ventricle free wall mechanics in metabolic syndrome without type-2 diabetes: effects of a 3-month lifestyle intervention program. Cardiovasc Diabetol (2014) 0.79
Effect of angiotensin II type 2 receptor-interacting protein on adipose tissue function via modulation of macrophage polarization. PLoS One (2013) 0.79
Jeju seaweeds suppress lipopolysaccharide-stimulated proinflammatory response in RAW 264.7 murine macrophages. Asian Pac J Trop Biomed (2014) 0.79
Metabolic actions of Rho-kinase in periphery and brain. Trends Endocrinol Metab (2013) 0.79
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. Int J Mol Sci (2013) 0.79
Insulin-related biomarkers to predict the risk of metabolic syndrome. Int J Endocrinol Metab (2013) 0.78
Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women. BMC Endocr Disord (2014) 0.78
Moderate-intensity exercise alters markers of alternative activation in circulating monocytes in females: a putative role for PPARγ. Eur J Appl Physiol (2016) 0.78
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus. J Diabetes Res (2016) 0.77
Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α. J Biol Chem (2016) 0.77
A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection. BMC Complement Altern Med (2014) 0.77
Increasing muscle mass improves vascular function in obese (db/db) mice. J Am Heart Assoc (2014) 0.77
Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet. Nutr Diabetes (2015) 0.77
Adipose tissue insulin sensitivity and macrophage recruitment: Does PI3K pick the pathway? Adipocyte (2013) 0.77
Retinol Binding Protein 4 in Relation to Diet, Inflammation, Immunity, and Cardiovascular Diseases. Adv Nutr (2015) 0.77
Pericardial Fat and Right Ventricular Morphology: The Multi-Ethnic Study of Atherosclerosis- Right Ventricle Study (MESA-RV). PLoS One (2016) 0.76
Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity. BMC Med Genomics (2015) 0.76
Blood Mercury and Insulin Resistance in Nondiabetic Koreans (KNHANES 2008-2010). Yonsei Med J (2015) 0.76
Effects of exercise on brain functions in diabetic animal models. World J Diabetes (2015) 0.76
Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression. J Biol Chem (2014) 0.76
Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of Atherosclerosis. Thromb Haemost (2014) 0.76
Highly purified eicosapentaenoic acid ameliorates cardiac injury and adipose tissue inflammation in a rat model of metabolic syndrome. Obes Sci Pract (2016) 0.75
Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease. J Clin Cell Immunol (2016) 0.75
Acute cyclooxygenase inhibition and baroreflex sensitivity in lean and obese adults. Clin Auton Res (2016) 0.75
Oral Gingival Cell Cigarette Smoke Exposure Induces Muscle Cell Metabolic Disruption. Int J Dent (2016) 0.75
STING-IRF3 Triggers Endothelial Inflammation in Response to Free Fatty Acid-Induced Mitochondrial Damage in Diet-Induced Obesity. Arterioscler Thromb Vasc Biol (2017) 0.75
Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice. Mol Ther Nucleic Acids (2016) 0.75
Compact NMR relaxometry of human blood and blood components. Trends Analyt Chem (2016) 0.75
Anti-inflammatory and immuno-modulatory studies on LC-MS characterised methanol extract of Gentiana kurroo Royle. BMC Complement Altern Med (2017) 0.75
Study of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome. Mediators Inflamm (2014) 0.75
Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest (2017) 0.75
Association between Dietary Patterns and Cardiovascular Risk Factors among Middle-Aged and Elderly Adults in Taiwan: A Population-Based Study from 2003 to 2012. PLoS One (2016) 0.75
Atrial Fibrillation: The Science behind Its Defiance. Aging Dis (2016) 0.75
Higher BMI is associated with reduced brain volume in heart failure. BMC Obes (2014) 0.75
Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes. J Diabetes Metab Disord (2017) 0.75
Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances. F1000Res (2016) 0.75
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice. PLoS One (2017) 0.75
Inhibition of insulin/PI3K/AKT signaling decreases adipose Sortilin 1 in mice and 3T3-L1 adipocytes. Biochim Biophys Acta (2017) 0.75
Relationship between rectus abdominis muscle thickness and metabolic syndrome in middle-aged men. PLoS One (2017) 0.75
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease. Clin Auton Res (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Cancer-related inflammation. Nature (2008) 34.21
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 12.07
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 11.28
Macrophage activation and polarization. Front Biosci (2008) 11.17
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 9.54
Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med (2009) 8.15
Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science (2011) 6.83
The many faces of PPARgamma. Cell (2005) 6.24
Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes (2007) 6.11
Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes (2005) 5.68
Protective immune mechanisms in helminth infection. Nat Rev Immunol (2007) 5.66
Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol (2008) 5.61
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 5.43
JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab (2007) 5.38
Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 5.10
Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol (2008) 4.89
Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes (2008) 4.56
Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest (2010) 4.56
Cytokine signaling modules in inflammatory responses. Immunity (2008) 4.09
Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol (1998) 3.98
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2010) 3.56
Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation (2004) 3.17
Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes (2006) 3.06
Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) (2007) 2.92
Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care (2007) 2.92
Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet--induced obesity in mice. Diabetes (2010) 2.76
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care (2009) 2.56
Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation (2008) 2.38
Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun (2009) 2.36
High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes (2002) 2.36
Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res (2008) 2.33
The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am (2008) 2.20
Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes (1996) 1.91
A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS One (2008) 1.90
Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol (2009) 1.82
The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol (2009) 1.66
Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes (2009) 1.59
TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab (2010) 1.48
MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J Exp Med (2009) 1.46
Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARgamma-/-, PPARdelta-/-, PPARgammadelta-/-, or LXRalphabeta-/- bone marrow. J Lipid Res (2008) 1.28
No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab (2000) 1.25
Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases. Ann Rheum Dis (2007) 1.10
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 8.30
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest (2002) 4.96
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature (2012) 4.31
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2010) 3.56
Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care (2007) 2.92
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci (2008) 2.54
Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem (2002) 1.99
Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J Biol Chem (2004) 1.97
Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity. Proc Natl Acad Sci U S A (2008) 1.83
Immunometabolism: an emerging frontier. Nat Rev Immunol (2011) 1.82
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2013) 1.68
Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A (2009) 1.61
Structure of the globular tail of nuclear lamin. J Biol Chem (2002) 1.58
Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice. Atherosclerosis (2011) 1.42
Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes. Diabetes (2007) 1.35
Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem (2003) 1.35
Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor. J Biol Chem (2002) 1.34
Kinase activation through dimerization by human SH2-B. Mol Cell Biol (2005) 1.22
Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol (2005) 1.11
Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes Care (2013) 1.10
Diabetes mutations delineate an atypical POU domain in HNF-1alpha. Mol Cell (2002) 1.08
Therapeutic approaches to target inflammation in type 2 diabetes. Clin Chem (2010) 1.03
Expansion and contraction: treating diabetes with bariatric surgery. Nat Med (2009) 1.01
Crystal structures of human TBC1D1 and TBC1D4 (AS160) RabGTPase-activating protein (RabGAP) domains reveal critical elements for GLUT4 translocation. J Biol Chem (2011) 0.99
A phenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol (2004) 0.99
Structural basis for HNF-4alpha activation by ligand and coactivator binding. J Biol Chem (2004) 0.98
NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy. Am J Respir Cell Mol Biol (2012) 0.95
NF-κB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy. Am J Physiol Lung Cell Mol Physiol (2011) 0.91
Multiple binding modes between HNF4alpha and the LXXLL motifs of PGC-1alpha lead to full activation. J Biol Chem (2009) 0.87
Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice. J Lipid Res (2011) 0.86
Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Invest Ophthalmol Vis Sci (2012) 0.85
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes. Diabetes Care (2013) 0.82
Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet. Am J Physiol Endocrinol Metab (2011) 0.82
Muscle-specific inhibition of the classical nuclear factor-κB pathway is protective against diaphragmatic weakness in murine endotoxemia. Crit Care Med (2014) 0.81
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest (2017) 0.81
Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes (2013) 0.80
Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol (1985) (2007) 0.79
Inflammation and obesity: STAMPing out insulin resistance? Immunol Cell Biol (2007) 0.79
When a domain is not a domain. Nat Struct Mol Biol (2008) 0.78
Sustained NF-κB activation and inhibition in β-cells have minimal effects on function and islet transplant outcomes. PLoS One (2013) 0.76
Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139. Diabetes Care (2014) 0.75
Genetic variability in insulin action inhibitor Ikkbeta (IKBKB) does not play a major role in the development of type 2 diabetes. J Clin Endocrinol Metab (2002) 0.75